Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
2.060
+0.030 (1.48%)
At close: Apr 28, 2026, 4:00 PM EDT
1.990
-0.070 (-3.39%)
After-hours: Apr 28, 2026, 7:01 PM EDT
Acurx Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 8 | 6 | 14 | 53 | 46 | 44 | |
| Market Cap Growth | -3.17% | -57.48% | -73.92% | 14.29% | 4.51% | - | |
| Enterprise Value | -0 | -0 | 8 | 46 | 36 | 30 | |
| Last Close Price | 2.03 | 2.49 | 16.28 | 76.60 | 79.60 | 86.43 | |
| PB Ratio | 0.90 | 1.11 | 22.35 | 11.30 | 6.31 | 3.56 | |
| P/TBV Ratio | 1.40 | 1.11 | 22.35 | 11.30 | 6.31 | 3.56 | |
| Net Debt / Equity Ratio | -1.43 | -1.43 | -6.03 | -1.60 | -1.25 | -1.04 | |
| Quick Ratio | 3.14 | 3.14 | 1.16 | 2.50 | 4.42 | 15.36 | |
| Current Ratio | 3.18 | 3.18 | 1.19 | 2.53 | 4.55 | 15.71 | |
| Return on Equity (ROE) | -270.80% | -270.80% | -534.03% | -243.33% | -122.61% | -168.71% | |
| Return on Assets (ROA) | -87.59% | -87.59% | -152.62% | -106.65% | -66.79% | -97.21% | |
| Return on Capital Employed (ROCE) | -153.60% | -153.60% | -2296.00% | -312.40% | -165.30% | -103.30% | |
| Earnings Yield | -107.96% | -136.25% | -102.56% | -27.64% | -26.21% | -28.88% | |
| Buyback Yield / Dilution | -85.46% | -85.46% | -27.56% | -17.15% | -26.72% | -37.88% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.